Thank you for your submission to EMBO reports. We have now received the enclosed reports from the two referees that were asked to assess your study. As you will see in their reports, they are both very positive about the study and only request minor revision, the most important concern being to more conclusively address the implications of your results for the mechanism of serpin folding (which is a major point of the study), as requested by referee 1.
Regarding referee 2's request of including supplementary figure 7 in the main text of the manuscript (which I agree with), I would add that it would also help the clarity of the study if supplementary figure 6 were included as the first two panels in figure 3.
I look forward to seeing a revised form of your manuscript when it is ready. In the meantime, do not hesitate to get in touch with me if I can be of any assistance.
Yours sincerely, Editor EMBO Reports REFEREE REPORTS:
Yamasaki et al. report on the structure of a new domain-swapped trimer of antitrypsin that is produced by heat-induced polymerization of the native serpin. The trimer structure is completely different from the s4A-s5A domain swapped dimer whose structure the authors published in 2008. The study begins to reconcile recent data published by the Lomas group showing that the pathologic polymers produced by the Z-antitrypsin variant are not produced by an s4A-s5A domain swap mechanism as was suggested by the authors in their earlier report. Using the monoclonal antibody produced by the Lomas group that specifically reacts with pathologic Z-antitrypsin polymers produced in vivo, the authors first duplicate the previous observation of the Lomas group that only heat-induced polymers of wild-type antitrypsin react with the antibody and that denaturant-induced polymers that favor the s4A-s5A domain swap mechanism weakly react. They then engineer an antitrypsin disulfide variant that blocks the denaturant-induced s4A-s5A domain swap polymers and show that heat-induced polymers still form. Using this variant, they produce, isolate and crystallize a preferred circular trimeric polymer to reveal an alternative domain swap mechanism involving the C-terminus including s1C, s4B and s5B. Another disulfide variant engineered to block this novel domain swap is shown to block the formation of heat-induced polymers. The authors cleverly use the two disulfide variants and a control disulfide variant to trap s4A-s5A domain swap and s1C-s4B-s5B domain swap polymers induced by denaturant and heat, respectively, providing convincing evidence of these two alternative domain swap mechanisms of polymerization. Significantly, the study engineers the disulfide variants on the polymerogenic Z antitrypsin variant to show that pathogenic polymers formed in yeast cells expressing the variants or in mammalian COS-7 cells involve the s1C-s4B-s5B domain swap. The authors speculate that the polymerogenic intermediate resulting in the domain swap is formed from another intermediate species on the normal folding pathway by RCL insertion into sheet A before the metastable fold is completed by intramolecular incorporation of s1C-s4B-s5B.
The study addresses a very controversial but highly important question concerning the mechanism by which mutant serpins form pathologic polymers that contribute to various diseases. The new structure is intriguing and has important implications not only for the mechanism of polymerization of mutants that destabilize the metastable fold but also for the folding pathway of serpins which the authors have duly noted. Importantly, the study makes the very significant finding that serpins can polymerize by different mechanisms depending on the stimulus used to induce polymerization. In fact, this would appear to be the third type of polymerization mechanism discovered when one includes the RCL-sheet A linked polymers that are induced by RCL peptides or RCL cleavage. The authors use of the Lomas antibody and disulfide trapping experiments to show that the new s1C-s4B-s5B domain swap polymers resemble those produced by the Z-antitrypsin mutation in vitro and in vivo provides strong evidence in support of this being the physiologic polymerization mechanism at least for the Z-variant.
But the implications for the serpin folding mechanism are more speculative. With regard to the authors proposal that the polymerogenic intermediate that is responsible for heat-induced polymerization of wild-type antitrypsin and polymerization of the Z antitrypsin variant involves RCL insertion into sheet A, the recent report of this group that RCL mutants which block the RCLsheet A mechanism do not affect the formation of heat-induced polymers (Yamasaki et al, 2010, JBC 285:30752) would seem to argue against this proposal since such RCL mutants should less readily form the polymerogenic intermediate. How can the authors reconcile their present results with these past results? Another issue of concern is how the new domain swap mechanism of polymerization squares with the hydrogen/deuterium exchange study of heat-induced polymerization by Wintrode (Tsutsui et al 2008, JBC 283:30804) . If these questions can be addressed, this timely and important study can be strongly recommended for publication in EMBO Reports.
Referee #2:
The study by Yamasaki et al describes a low resolution crystal structure of a trimeric form of alpha-1-antitrypsin (AT), together with elegant disulfide trapping studies, and monoclonal antibody binding studies, to characterize specific domain swapping pathways associated with pathologic polymerization of AT, and potentially other serpins. The precise nature of serpin pathologic polymers formed in vivo is currently controversial and this report describes a novel potential pathway. The study is well performed, the manuscript well written, and the results clearly presented and concise. A major strength of the report is the elegant use of disulfide trapping studies to show specific domain swap pathways and to correlate these pathways with polymers formed in vivo by use of a previously described conformationally sensitive monoclonal antibody. There are no perceived significant shortcomings of the manuscript. The principal results of the study, that serpin polymerization follows a domain swap pathway involving the c-terminal region of the protein, together with the proposed model for how mutations in serpins can affect folding intermediates in a way that promotes this pathway and can lead to pathologic polymers in vivo, are novel and convincing. Thus, this is a significant study that addresses an important and controversial issue. The only minor suggested changes are indicated below. 1 -The model for serpin pathologic polymerization shown in figure S7 should be included in the main manuscript. This figure very nicely describes the proposed mechanism and is central to the discussion of the results, as such the reader should have ready access to this figure. 2 -It would be helpful for the reader if the authors could include for all of the gels arrows or some other indicators to show either approximate molecular masses of different species, or at a minimum on the native gels an indicator of the major band and some description of its form (for example monomer, trimer, etc). Response to referees' comments: Referee #1 asked how we reconciled the present results with our previous study on RCL variants of α1AT (Yamasaki M, Sendall TJ, Harris LE, Lewis GM, Huntington JA., J Biol Chem. 2010 Oct 1;285(40):30752-8.). We mutated hydrophobic residues from P8-P6 to aspartic acids, and demonstrated that the variant was not able to polymerize when induced by small peptides corresponding to P14-P9 or, importantly, when cleaved at the P10-P9 bond. These results demonstrated that the P8-P3 region on its own can not mediate an intermolecular loop-sheet polymer. However, we also showed that in the context of the full RCL (i.e. P1-P1' cleavage), the variant was able to insert the mutated region. We demonstrated this by increased stability and by solving crystal structures of the cleaved variants. We concluded that the mutations precluded the loop-sheet mechanism as currently formulated; namely, that the P8-P3 region of one serpin monomer inserts in register into the A sheet of another monomer. In other words, the P8-P6 region is either a small part of a large domain swap (as in the s4A/s5A model), or is not a part of the swapped region (as in our C-terminal model). Indeed, if our hypothesized folding mechanism is correct, one would expect that mutations that slowed RCL incorporation should rescue, to some degree, the folding defect of Z-α1AT by slowing the formation of L*. This is what we observed and reported in the paper in question (Fig. 4C in the secreted fraction). Our current study is thus consistent with our previous findings regarding the role of the P8-P6 region of the RCL. Heat induced polymerization was also studied by the Tsutsui paper mentioned by the referee (Tsutsui Y, Kuri B, Sengupta T, Wintrode PL., J Biol Chem. 2008 Nov 7;283(45):30804-11.), and the results were interpreted as supporting a loop-sheet type mechanism of polymerization. In that study, the authors incubated wild-type α1AT at 45C to induce the M* state and to form polymers for H/D exchange studies. Of particular relevance to our work, they found that the only region that appeared to exchange faster at 45C than at 25C was sheet C, and concluded that the M* state does not have an appreciable amount of unfolded regions and appears essentially native (with the exception of sheet C). However, the rate of polymerization at 45C for wild-type α1AT is exceedingly slow, indicating that the M* state is not highly populated. They show that polymers can form after incubation for 4 days at 0.1mg/ml, but no polymerization occurs with incubations up to 5000sec. We conclude that the near native H/D exchange rates for wild-type α1AT at 45C were found precisely because the native state predominates under these conditions. The results do not, therefore, reflect the ensemble of partially denatured states populated by incubating serpins near their Tm's (the method traditionally used to produce polymers within minutes), and has no bearing whatsoever on the folding of serpins, either in vitro or within cells.
The second referee asked us to include supplementary figure S7 into the main body of the article as figure 4. This has been done, and the corresponding figure legend has been added. He also wanted molecular weight standards shown for all gels in Fig. 3 . This has been done.
In response to the editor, we have also incorporated supplementary figure S6 as the last two panels of Fig 3. Thank you for the submission of your revised study to EMBO reports. It has been seen by referee 1 of the previous submission, who is satisfied with your reply to his/her concern regarding the mechanism of serpin folding. I think this revised version also addresses the other issues brought up during the previous round of peer-review, so I would in principle be happy to accept your manuscript for publication.
However, both this referee and myself think it would benefit the study to include this discussion in the manuscript, as other readers might have similar concerns. In order to accommodate this, I am happy to extend our length limit to a maximum of 30,000 characters, as needed. In addition, I cannot formally accept your study until you provide us with the Protein Data Bank accession codes for the structure you have solved.
Once you have made these modifications and provided us with a corrected file (which you can do by sending us a word document in reply to this email), we will be happy to accept your study for publication and you will receive further instructions from the editorial office on how to proceed.
Thank you for considering EMBO reports for publication and all the best for your future work. 
